Average Co-Inventor Count = 5.43
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Epimmune Inc. (7 from 17 patents)
2. Pharmexa Inc. (3 from 6 patents)
3. Genimmune N.v. (2 from 3 patents)
4. Ose Pharma International Sa (2 from 2 patents)
5. Cytel Corporation (1 from 34 patents)
6. Biotech Synergy, Inc. (1 from 1 patent)
15 patents:
1. 9913884 - HLA-A2 tumor associated antigen peptides and compositions
2. 9394350 - HLA-A2 tumor associated antigen peptides and compositions
3. 9340577 - HLA binding motifs and peptides and their uses
4. 8007810 - HLA-A2 tumor associated antigen peptides and compositions
5. 7888472 - Optimized multi-epitope constructs and uses thereof
6. 7611713 - Inducing cellular immune responses to hepatitis B virus using peptide compositions
7. 7572882 - Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
8. 7507803 - Optimized multi-epitope constructs and uses thereof
9. 7462354 - Method and system for optimizing minigenes and peptides encoded thereby
10. 7026443 - Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
11. 6689363 - Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
12. 6602510 - HLA class I A2 tumor associated antigen peptides and vaccine compositions
13. 6534482 - Expression vectors for stimulating an immune response and methods of using the same
14. 6322789 - HLA-restricted hepatitis B virus CTL epitopes
15. 6033667 - Method for detecting the presence of P-selectin